Market Overview

UPDATE: Goldman Sachs Raises PT on Vitamin Shoppe from $56 to $64


Goldman Sachs reiterated a Neutral rating on Vitamin Shoppe (NYSE: VSI) and increased its price target from $56 to $64.

Goldman Sachs wrote, “VSI's 2Q results were marked by improved SSS momentum relative to sector data and peers; nice acceleration in e-commerce sales; and, ongoing operating leverage. SSS are now firmly delivering on the potential associated with rapid unit growth.”

Vitamin Shoppe closed at $60.52 on Tuesday.

Posted-In: Goldman SachsAnalyst Color Price Target Analyst Ratings


Related Articles (VSI)

View Comments and Join the Discussion!

Partner Center